ZyVersa Therapeutics ZVSA
OTC ZVSA
$0.00 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

ZyVersa Therapeutics, Inc. (ZVSA) Accounts Payables (2022 - 2026)

Updated

ZyVersa Therapeutics (ZVSA) reported Accounts Payables of $10.24 million for Q1 2026, up 6.6% from $9.6 million a year earlier and up 1.1% from the prior quarter.

Analysis

ZyVersa Therapeutics, Inc. (ZVSA) Accounts Payables (2022 - 2026) Analysis & Trends

At the end of FY2025, ZyVersa Therapeutics posted Accounts Payables of $10.12 million, up 8.4% from FY2024.

  • By year, Accounts Payables came in at $9.34 million in FY2024 (+10.7%) and $8.43 million in FY2023.
  • The Q1 2026 figure ranks as the highest quarterly Accounts Payables in data going back to Q4 2022.
  • Year over year, Accounts Payables has now increased in each of the last ten quarters, with growth averaging 9.2% over the last eight quarters.
  • Across the past five years, year-over-year growth in Accounts Payables ran from 2.1% in Q2 2024 to 39.9% in Q4 2023.
  • Per Business Quant data, the three quarters before Q1 2026 came in at $10.12 million (Q4 2025), $9.81 million (Q3 2025) and $9.77 million (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 10.24 Mn
Dec 31, 2025 10.12 Mn
Sep 30, 2025 9.81 Mn
Jun 30, 2025 9.77 Mn
Mar 31, 2025 9.60 Mn
Dec 31, 2024 9.34 Mn
Sep 30, 2024 9.28 Mn
Jun 30, 2024 8.32 Mn
Mar 31, 2024 8.13 Mn
Dec 31, 2023 8.43 Mn
Sep 30, 2023 8.90 Mn
Jun 30, 2023 8.14 Mn
Mar 31, 2023 6.38 Mn
Dec 31, 2022 6.03 Mn
API Access

ZyVersa Therapeutics, Inc. Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=ZVSA&period=max&api_key=YOUR_API_KEY